Yahoo Web Search

Search results

    • Q4 2024 Roivant Sciences Ltd Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 minutes ago

      And then, we have some other readouts coming, including the namilumab in sarcoidosis later this year, and some data and expected -- and our future plans in this undisclosed program that I mentioned ...